Watchdog: Medicare spending on opioids rising

Published



Medicare spending on opioids has grown in the last decade, raising concerns about fraud and drug abuse, an inspector general has found.

Spending for Medicare Part D, the program’s prescription drug benefit, has risen by more than $10 billion annually between 2006 and 2015, the Department of Health and Human Services inspector general found in a new report.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.